{
    "clinical_study": {
        "@rank": "67133", 
        "arm_group": [
            {
                "arm_group_label": "Statin group", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo group", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to examine the association between preoperative statin treatment\n      and the incidence of postoperative acute kidney injury(AKI) in patients undergoing valvular\n      heart surgery."
        }, 
        "brief_title": "The Effects of Statin on Postoperative Renal Function in Valvular Heart Surgery: a Randomized, Placebo-controlled Study", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Kidney Injury", 
        "condition_browse": {
            "mesh_term": [
                "Acute Kidney Injury", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - patients over the age of 20 scheduled for valvular heart surgery\n\n        Exclusion Criteria:\n\n          1. Current statin use\n\n          2. Left ventricular ejection fraction < 30%\n\n          3. Preexisting congestive heart failure\n\n          4. Severe coronary artery disease\n\n          5. Hemodynamically unstable arrhythmia\n\n          6. Cardiogenic shock during perioperative period\n\n          7. Ventricular assist device\n\n          8. Severe renal dysfunction (eGFR < 15 ml/min per 1.73 m2)\n\n          9. History of liver disease or elevated serum transaminases\n\n         10. History of rhabdomyolysis or elevated creatinine kinase"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01909739", 
            "org_study_id": "4-2013-0334"
        }, 
        "intervention": [
            {
                "arm_group_label": "Statin group", 
                "description": "Atrovastatin 80mg was administered orally on the evening before surgery. Before anesthesia induction, atrovastatin 40mg was administered orally. And atrovastatin 40mg were administered orally in the evening of postoperative days 0, 1, and 2.", 
                "intervention_name": "atrovastatin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo group", 
                "description": "Placebo 80mg was administered orally on the evening before surgery. Before anesthesia induction, placebo 40mg was administered orally. And placebo 40mg were administered orally in the evening of postoperative days 0, 1, and 2.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "AKI, atrovastatin, Valvular heart surgery", 
        "lastchanged_date": "February 4, 2014", 
        "location": {
            "contact": {
                "email": "YLKWAK@yuhs.ac", 
                "last_name": "Young Lan Kwak, MD", 
                "phone": "82-2-2228-2420"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "YLKWAK@yuhs.ac", 
            "last_name": "Young Lan Kwak, MD", 
            "phone": "82-2-2228-2420"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "BUN/Cr cystatin C eGFR urine output incidence of acute kidney injury(based on the AKIN criteria)", 
            "measure": "Comparison of postoperative renal function with or without statin in patients undergoing valvular heart surgery", 
            "safety_issue": "No", 
            "time_frame": "renal function change from 24-hour after surgery to 120-hour after surery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01909739"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}